CDC director’s COVID returns as examine finds such rebounds shockingly frequent

A woman adjusts her face mask while sitting in front of a microphone.

Enlarge / Rochelle Walensky, director of the US Facilities for Illness Management and Prevention (CDC), adjusts her protecting masks throughout a Senate Well being, Schooling, Labor, and Pensions Committee listening to in Washington, DC. (credit score: Getty | Bloomberg)

Rochelle Walensky, director of the Facilities for Illness Management and Prevention, has skilled a COVID-19 rebound—a return of gentle signs and constructive exams after finishing a course of the antiviral drug Paxlovid and testing adverse—the CDC introduced at present.

Walensky first examined constructive on October 21 and skilled gentle signs. She accomplished a five-day course of Paxlovid, recovered, and examined adverse. However on Sunday, October 30, her gentle signs returned, and she or he as soon as once more examined constructive, the company reported.

Walensky now joins the ever-growing ranks of individuals reporting rebounds after Paxlovid, together with high-profile rebounders comparable to President Biden and prime infectious illness professional Anthony Fauci. However, in accordance with a small examine printed in JAMA Community Open final week, rebounds could also be surprisingly frequent in all COVID-19 circumstances—even these not handled with Paxlovid.

Learn 6 remaining paragraphs | Feedback

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *